$240.470
-2.501 (-1.04%)收盤時
SXI 資訊
SXI 事件
Standex Declares Quarterly Cash Dividend of $0.36
Standex has declared a quarterly cash dividend of 36c per share, an approximately 5.9% year-on-year increase. The dividend is payable November 20 to shareholders of record on November 6.
Standex Appoints Samantha Stoddard as CFO
Standex (SXI) announced the appointment of Samantha Stoddard as Vice President, CFO and Treasurer, effective December 1, 2026. Stoddard will join Standex from Jeld-Wen Holding (JELD), where she currently serves as Executive Vice President and CFO. She will report directly to David Dunbar, Standex's Chairman, President and CEO. Stoddard will succeed Ademir Sarcevic, who, as previously announced in May 2026, was promoted to Executive Vice President - Corporate and Group President - Electronics and has continued to serve as CFO during the search for his successor. Sarcevic will remain CFO until Stoddard joins on December 1, after which he will focus fully on driving accelerated growth across the company's Electronics segment and overseeing certain corporate projects and initiatives.
Standex Acquires Remaining 9.9% Stake in Narayan Powertech for Approximately $64M
Standex has acquired the remaining 9.9% interest in India-based Narayan Powertech, a manufacturer of low voltage and medium voltage instrument transformers, for approximately $64M.
Company Expects FY26 Sales Growth of Approximately $100M
The Company's prior FY26 sales outlook included a full year contribution from Federal Industries. Considering the divestiture of Federal Industries and barring any unforeseen economic, global trade, or tariffs related disruptions, the Company now expects revenue to grow by approximately $100M in FY26, which will continue to be driven by mid-to-high single digit organic growth in Electronics and double-digit organic growth in Aerospace & Defense. The Company remains on course to release over fifteen new products that it expects will contribute approximately 300 bps of incremental growth. Sales from fast growth markets are on track to grow approximately 45% year-on-year and reach approximately $270M.
Company Expects Slight Revenue Increase in Fiscal Q4
The company said, "In fiscal Q4, on a year-on-year basis, the Company expects slightly to moderately higher revenue, driven by mid-to-high single digit organic growth from higher sales into fast growth end markets and increased new product sales, partially offset by the impact on revenue from the recently completed divestiture of Federal Industries. The Company expects slightly lower adjusted operating margin as contributions from organic growth and realization of productivity actions are more than offset by growth investments, higher medical costs, and increased variable compensation expenses. On a sequential basis, the Company expects slightly higher revenue, driven by increased contributions from fast growth end markets and new product sales, and slightly to moderately higher adjusted operating margin due to higher volume and pricing and productivity initiatives, partially offset by growth investments."
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。